Patents by Inventor Patrick de Boever

Patrick de Boever has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210383262
    Abstract: A computing system configured to perform the steps of dividing both a saliency map and a ground-truth feature map into cells in order to obtain segmented saliency map and a segmented feature map, wherein a relevance score is assigned to each cell based on values of individual pixels within the cells in the saliency map and feature map, selecting, for both the segmented saliency map and segmented feature map, a selected number of selected cells corresponding to the most relevant cells having highest relevance scores within the segmented saliency map and the segmented feature map, respectively, and computing a level of agreement between the segmented saliency map and the segmented feature map by comparing the selected cells having highest relevance scores in the segmented saliency map to the selected cells having highest relevance scores in the segmented feature map.
    Type: Application
    Filed: June 8, 2021
    Publication date: December 9, 2021
    Inventors: Bart ELEN, Nele GERRITS, Toon VAN CRAENENDONCK, Patrick DE BOEVER
  • Patent number: 10683547
    Abstract: A method relates to epigenetic markers and their diagnostic and predictive value for respiratory allergy. The method can include assaying a test sample from the patient for a DNA hypermethylation or hypomethylation of at least GLI2 region, in which hypermethylation or hypomethylation of the gene region in the test sample indicates or predicts a respiratory allergy in the patient.
    Type: Grant
    Filed: May 27, 2016
    Date of Patent: June 16, 2020
    Assignee: VITO NV
    Inventors: Patrick de Boever, Sabine Langie
  • Publication number: 20180148785
    Abstract: A method relates to epigenetic markers and their diagnostic and predictive value for respiratory allergy. The method can include assaying a test sample from the patient for a DNA hypermethylation or hypomethylation of at least GLI2 region, in which hypermethylation or hypomethylation of the gene region in the test sample indicates or predicts a respiratory allergy in the patient.
    Type: Application
    Filed: May 27, 2016
    Publication date: May 31, 2018
    Inventors: Patrick de Boever, Sabine Langie